Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer
Weikang Kong, Lingxia Zhu, Tian Li, Jiao Chen, Bo Fan, Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun, Peng Cao
Topics & Concepts
Pancreatic cancerPAK1Cancer researchCancerProtein kinase BKinaseIn vivoMedicineCancer cellApoptosisMalignancyInternal medicineBiologyBiochemistryBiotechnologyCancer Mechanisms and TherapyPancreatic and Hepatic Oncology ResearchHistone Deacetylase Inhibitors Research